Announcement PDF NEUREN PHARMACEUTICALS LIMITED ANNUAL GENERAL MEETING Wednesday, 27 May, 2026 RESULT OF ANNUAL GENERAL MEETING (ASX REPORT) MUFG Corporate Markets A division of MUFG Pension & Market Services As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda. Resolution Voted on at the meeting Proxy Votes (as at proxy close) Total votes cast in the poll (where applicable) No Short Description Strike Y/N/NA For Against Discretionary (OpenVotes) Abstain For Against Abstain ** Result 1 RE-ELECTION OF DIRECTOR - JOE BASILE NA 53,645,115 4,305,931 71,060 2,641 56,578,836 4,530,332 121,806 Carried 92.46% 7.42% 0.12% 92.59% 7.41% 2 AUDITOR REMUNERATION NA 57,715,017 228,630 70,931 10,169 60,209,097 892,543 129,334 Carried 99.48% 0.39% 0.12% 98.54% 1.46% 3 ISSUE OF OPTIONS TO MANAGING DIRECTOR - JONATHAN PILCHER NA 48,788,280 7,599,324 70,260 66,883 51,702,461 7,961,530 66,983 Carried 86.42% 13.46% 0.12% 86.66% 13.34% 4 AMENDMENTS TO THE COMPANY'S CONSTITUTION NA 41,215,748 16,725,242 73,797 9,960 43,662,959 17,389,190 178,825 Not Carried 71.04% 28.83% 0.13% 71.52% 28.48% ** - Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item Printed: 27/05/2026 03:40:38 PM This report was produced from the MUFG Pension & Market Services Meeting System Page 1 of 1